{"meta":{"query_hash":"04f387a918cf","filters":{"venue":"Journal of Chemotherapy"},"cohort_total":36,"direct_labels_cover":0,"predictions_cover":36,"exported":36,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/04f387a918cf","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Chemotherapy"},"results":[{"id":"W1970284883","doi":"10.1179/joc.2006.18.4.366","title":"Application of Two Methods to Determine Killing of<i>Streptococcus pneumoniae</i>by Various Fluoroquinolones","year":2006,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital","funders":"","keywords":"Streptococcus pneumoniae; Gatifloxacin; Moxifloxacin; Microbiology; Levofloxacin; Antimicrobial; Minimum inhibitory concentration; Ofloxacin; Drug; Antibiotics; Multiple drug resistance; Drug resistance; Streptococcaceae; Biology; Pharmacology; Ciprofloxacin","score_opus":0.011953478913849845,"score_gpt":0.334304866985249,"score_spread":0.3223513880713992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970284883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8703576,0.0005139888,0.1263519,0.0020249672,0.00013752292,0.0002916157,0.0000051020206,0.000015211851,0.000302097],"genre_scores_gemma":[0.984881,0.00012401136,0.013906452,0.00060622895,0.0003147829,0.000010082397,0.000001733505,0.000028081122,0.00012766186],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987147,0.00005574353,0.00074319006,0.00011305974,0.00022944686,0.00014385034],"domain_scores_gemma":[0.9986305,0.0000992679,0.0006405679,0.00021502096,0.00031969382,0.000094909614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003620055,0.00012953348,0.00050037913,0.00021414395,0.000031691583,0.000005897255,0.00011001488,0.00008029331,0.00002071348],"category_scores_gemma":[0.000026401221,0.000101243386,0.00021309292,0.00028399823,0.0000557883,0.000058969188,0.000008996921,0.00016370915,0.000001782281],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048112866,0.00027895026,0.02457013,0.000038295533,0.00007328194,0.00000344564,0.00009646215,0.00013779629,0.896089,0.000023917313,0.00039190907,0.07824869],"study_design_scores_gemma":[0.0019365863,0.00088168716,0.014533017,0.000105362225,0.00010569439,0.00020565373,0.000016913928,0.00023977348,0.92699516,0.0004834312,0.054388583,0.00010815183],"about_ca_topic_score_codex":0.00002876819,"about_ca_topic_score_gemma":0.00000307719,"teacher_disagreement_score":0.114523366,"about_ca_system_score_codex":0.000046221692,"about_ca_system_score_gemma":0.00007726117,"threshold_uncertainty_score":0.41285855},"labels":[],"label_agreement":null},{"id":"W1974794853","doi":"10.1179/joc.2006.18.4.373","title":"Relative Potential for Selection of Quinolone-Resistance- Determining-Region Mutations in<i>Streptococcus pneumoniae</i>by Gemifloxacin, Gatifloxacin and Moxifloxacin","year":2006,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Gatifloxacin; Gemifloxacin; Moxifloxacin; DNA gyrase; Quinolone; Streptococcus pneumoniae; Microbiology; Topoisomerase IV; Levofloxacin; Sparfloxacin; Ciprofloxacin; Medicine; Pharmacology; Biology; Antibiotics; Ofloxacin; Genetics; Escherichia coli; Gene","score_opus":0.007676465040214943,"score_gpt":0.26060307167367724,"score_spread":0.2529266066334623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974794853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886785,0.00033444684,0.007953725,0.0022268984,0.00012125172,0.00045646023,0.000010989344,0.000015788935,0.00020193384],"genre_scores_gemma":[0.9982706,0.0001438034,0.00067194935,0.00020211806,0.0002105581,0.000022166434,0.0000056363633,0.000028650278,0.00044453552],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985937,0.00005358023,0.0007627396,0.00017108867,0.00021336645,0.00020554621],"domain_scores_gemma":[0.9987142,0.00010645685,0.00065781357,0.00010271032,0.0003379161,0.00008087561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019332685,0.00017433299,0.00046558236,0.00033392172,0.00008717614,0.000016441614,0.000054952397,0.00015943935,0.000011483775],"category_scores_gemma":[0.000054791974,0.00015030561,0.00018929958,0.00029304082,0.00012271029,0.00023100832,0.000005330021,0.0002619781,4.473242e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040433827,0.00038099944,0.08168755,0.00010500346,0.00011926347,0.000022734064,0.00035669105,0.00019147662,0.91204405,0.00007393234,0.0016986671,0.0029152883],"study_design_scores_gemma":[0.023999343,0.004214367,0.4739188,0.0010815585,0.00057693763,0.0010335159,0.00042262138,0.0016630313,0.46601477,0.007201262,0.019223774,0.0006500301],"about_ca_topic_score_codex":0.00000922855,"about_ca_topic_score_gemma":0.0000431966,"teacher_disagreement_score":0.44602928,"about_ca_system_score_codex":0.00011393863,"about_ca_system_score_gemma":0.00014274522,"threshold_uncertainty_score":0.6129285},"labels":[],"label_agreement":null},{"id":"W1984982601","doi":"10.1179/joc.2007.19.5.546","title":"Comparative Cytotoxicity of C-1311 in Colon Cancer<i>In Vitro</i>and<i>In Vivo</i>Using the Hollow Fiber Assay","year":2007,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Oxaliplatin; Capecitabine; Paclitaxel; Cytotoxicity; Growth inhibition; Colorectal cancer; In vivo; Cell growth; Chemotherapy; Pharmacology; Biology; MTT assay; Phases of clinical research; In vitro; Cancer research; Internal medicine; Cancer; Medicine; Biochemistry","score_opus":0.01857560441777594,"score_gpt":0.31279087514229365,"score_spread":0.2942152707245177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984982601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966214,0.0020690025,0.0006360578,0.00023563,0.000093188,0.00014450599,0.000007749852,6.5748935e-7,0.0001918506],"genre_scores_gemma":[0.9977025,0.0009315098,0.0006282433,0.0005455822,0.00011516351,0.000002157692,4.315584e-7,0.000012208796,0.00006225106],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99907273,0.00006461769,0.0004090781,0.00011908867,0.00014257214,0.00019191828],"domain_scores_gemma":[0.9994569,0.000037418133,0.00029202475,0.00010940059,0.000065880886,0.00003838525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009096322,0.00011607448,0.00030598132,0.000095600924,0.000017700893,0.0000086749005,0.00013924617,0.0001039741,0.0000261501],"category_scores_gemma":[0.0000066206,0.00008823371,0.00007968109,0.00016036008,0.000063183536,0.0000060881675,0.000017819864,0.00016186577,5.660061e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017215823,0.00010194731,0.00088675396,0.000007712436,0.000037942813,0.000006509943,0.000510074,0.0003735556,0.99348193,0.0000082653605,0.000028285589,0.0028354216],"study_design_scores_gemma":[0.00230206,0.00016616004,0.0016567471,0.000057428082,0.0000075803014,0.000020716536,0.00015133216,0.0002197018,0.99150926,0.00015348317,0.003661287,0.00009421934],"about_ca_topic_score_codex":0.00009025231,"about_ca_topic_score_gemma":0.0009191783,"teacher_disagreement_score":0.0036330014,"about_ca_system_score_codex":0.00007019655,"about_ca_system_score_gemma":0.000111471694,"threshold_uncertainty_score":0.35980663},"labels":[],"label_agreement":null},{"id":"W1986405458","doi":"10.1179/joc.2011.23.1.32","title":"Trastuzumab and Vinorelbine in Early Stages of HER2-Positive Breast Cancer","year":2011,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Vinorelbine; Trastuzumab; Oncology; Medicine; Breast cancer; Internal medicine; Chemotherapy; Cancer; Cisplatin","score_opus":0.027853901849152547,"score_gpt":0.3377025580965879,"score_spread":0.30984865624743535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986405458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951889,0.0018068443,0.000026282662,0.0018781708,0.000058328937,0.00015701343,0.000017021308,0.0000033498009,0.00086412264],"genre_scores_gemma":[0.9952223,0.0034773014,0.0006419756,0.00027013023,0.00016242336,0.0000030751928,2.5651659e-7,0.00002541576,0.00019717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886465,0.00004624306,0.00039970715,0.00010555464,0.00039046354,0.00019339229],"domain_scores_gemma":[0.9992021,0.000043417385,0.00021599284,0.00011482336,0.00028282873,0.00014087935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037500402,0.00010838768,0.0004132236,0.00021109205,0.000011960879,0.000007122585,0.00010324153,0.0000719589,0.0006534326],"category_scores_gemma":[0.000015366386,0.000081537655,0.0000757304,0.00019200316,0.00013477405,0.00010118124,0.000011656447,0.00033887982,9.90863e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039508343,0.00060243753,0.83830667,0.00016225681,0.00023689159,0.00018519198,0.0087854685,0.0000010825139,0.056725428,0.000028255607,0.00084442436,0.09017107],"study_design_scores_gemma":[0.0037590726,0.0013809833,0.91239476,0.0005811049,0.000023548184,0.00032879613,0.00018285334,0.0000053327617,0.080794126,0.0001405773,0.000335335,0.00007353107],"about_ca_topic_score_codex":0.00058622984,"about_ca_topic_score_gemma":0.000048973485,"teacher_disagreement_score":0.09009754,"about_ca_system_score_codex":0.00015968634,"about_ca_system_score_gemma":0.00027797028,"threshold_uncertainty_score":0.7154629},"labels":[],"label_agreement":null},{"id":"W1990911266","doi":"10.1179/joc.2007.19.2.146","title":"Antimicrobial Efficacy of Gatifloxacin and Moxifloxacin with and without Benzalkonium Chloride Compared with Ciprofloxacin and Levofloxacin Against Methicillin- Resistant<i>Staphylococcus aureus</i>","year":2007,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Royal University Hospital","funders":"","keywords":"Gatifloxacin; Moxifloxacin; Benzalkonium chloride; Levofloxacin; Ciprofloxacin; Staphylococcus aureus; Microbiology; Antimicrobial; Medicine; Chemistry; Antibiotics; Bacteria; Biology","score_opus":0.014440794711889929,"score_gpt":0.2847500317379832,"score_spread":0.2703092370260933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990911266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932231,0.0017691479,0.0024450568,0.0015404518,0.00006869948,0.000554828,0.00001497309,0.00002112032,0.0003626556],"genre_scores_gemma":[0.98480767,0.0022377314,0.0113874,0.0011096414,0.00028858052,5.6150327e-7,0.000005486485,0.000083265164,0.00007964718],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99750984,0.00005810588,0.0009748624,0.00039342663,0.0005981432,0.0004656097],"domain_scores_gemma":[0.9976091,0.00023164427,0.00084375613,0.00030352792,0.0005465304,0.00046546274],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011792702,0.0004542635,0.0012050333,0.00041654464,0.00012344772,0.00005839753,0.00013821987,0.00018343375,0.000010543744],"category_scores_gemma":[0.000053401498,0.00030984744,0.00010012812,0.00038613135,0.0006723786,0.00014558695,0.000039573697,0.0006879427,3.397504e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023464363,0.00044067967,0.05112752,0.0003874325,0.00062013685,0.00013419993,0.001467893,0.000062534426,0.91798484,0.000063402105,0.00028607674,0.003960919],"study_design_scores_gemma":[0.026719162,0.0023876638,0.12643276,0.0012707346,0.00053406286,0.00017508717,0.0004217657,0.00025330755,0.83904266,0.00003474271,0.0022535755,0.00047449235],"about_ca_topic_score_codex":0.000019802821,"about_ca_topic_score_gemma":0.000028947466,"teacher_disagreement_score":0.0789422,"about_ca_system_score_codex":0.00004690409,"about_ca_system_score_gemma":0.00018919028,"threshold_uncertainty_score":0.9999354},"labels":[],"label_agreement":null},{"id":"W1998609714","doi":"10.1179/joc.2009.21.1.16","title":"Antimicrobial Susceptibility Among Bacterial Isolates from ICU and Non-ICU Settings and Different Age Groups: Results from the Tigecycline Evaluation and Surveillance Trial in North America","year":2009,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Tigecycline; Linezolid; Medicine; Meropenem; Imipenem; Amikacin; Cefepime; Vancomycin; Acinetobacter baumannii; Microbiology; Antimicrobial; Antibiotics; Antibiotic resistance; Biology; Staphylococcus aureus","score_opus":0.007140946014033651,"score_gpt":0.24888068381567147,"score_spread":0.24173973780163782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998609714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981701,0.00033382868,0.00006967067,0.00085609447,0.00017676277,0.00029941314,0.00008554651,0.0000022635516,0.000006324521],"genre_scores_gemma":[0.9966149,0.0016846941,0.00042964556,0.00027362493,0.00083962746,5.6769653e-7,0.00014079806,0.000011276747,0.0000048749475],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998674,0.00018665404,0.00054980366,0.00030026486,0.00013834113,0.00015093188],"domain_scores_gemma":[0.99904245,0.00011751278,0.0004944238,0.00020700064,0.00007934914,0.000059283917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004980791,0.00017897986,0.00035016326,0.000023931372,0.0000516167,0.00009495627,0.00012635694,0.00012278072,0.0000094416855],"category_scores_gemma":[0.00019167057,0.0001223247,0.000056236157,0.00004980378,0.00017405434,0.000017746319,0.000028983173,0.0001476365,1.0288352e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024484465,0.00011643682,0.26840723,0.000003955427,0.000060714647,0.000004473993,0.00057036075,0.0000026992027,0.6947489,5.8210887e-8,0.00035386166,0.0112468675],"study_design_scores_gemma":[0.020531254,0.00046941292,0.9663689,0.00004124558,0.000017726328,0.000004072027,0.000054906013,0.00007785163,0.012022228,0.000073494266,0.00020115262,0.0001377397],"about_ca_topic_score_codex":0.00007457777,"about_ca_topic_score_gemma":0.0006335547,"teacher_disagreement_score":0.6979617,"about_ca_system_score_codex":0.000019549796,"about_ca_system_score_gemma":0.000032519405,"threshold_uncertainty_score":0.4988256},"labels":[],"label_agreement":null},{"id":"W2004481186","doi":"10.1179/joc.2009.21.5.527","title":"Prescription of Antibiotics in Intensive Care Units in Latin America: An Observational Study","year":2009,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Antibiotic Use and Resistance","field":"Immunology and Microbiology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Observational study; Medical prescription; Antibiotics; Medicine; Intensive care medicine; Latin Americans; Intensive care; Antibacterial agent; Internal medicine; Pharmacology; Biology; Microbiology; Political science","score_opus":0.06077571461327468,"score_gpt":0.3142668172654434,"score_spread":0.25349110265216873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004481186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981577,0.0011895563,0.000048710674,0.00031496046,0.00010812718,0.00012013162,0.0000029489486,0.0000028213924,0.00005507048],"genre_scores_gemma":[0.9990281,0.00019907553,0.00018728715,0.00047489224,0.000023832255,2.4989427e-8,0.0000066859734,0.0000052843475,0.000074834614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992065,0.00010992468,0.00044197525,0.00008228201,0.0000494578,0.0001098822],"domain_scores_gemma":[0.999,0.000031921227,0.0003185148,0.000094561474,0.0005445014,0.000010469436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013112124,0.00008202056,0.00028852347,0.0001568179,0.000016513886,0.00000386162,0.00012646746,0.00009135932,0.000027115446],"category_scores_gemma":[0.00006408511,0.000065638225,0.000033902503,0.0002656644,0.000054570562,0.00010817796,0.0000048736806,0.00022811515,0.0000012445845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010405198,0.0007497213,0.4865851,0.000017672895,0.000074956566,0.000024853838,0.024829138,0.0001401528,0.47544459,0.00007645346,0.00033356133,0.01068327],"study_design_scores_gemma":[0.0027333887,0.001446924,0.928065,0.00017043512,0.0000092873925,0.00001120326,0.02113212,0.000007813982,0.045970064,0.00010688706,0.00027447176,0.000072384726],"about_ca_topic_score_codex":0.000030092928,"about_ca_topic_score_gemma":0.000057209545,"teacher_disagreement_score":0.4414799,"about_ca_system_score_codex":0.000035690413,"about_ca_system_score_gemma":0.00008256021,"threshold_uncertainty_score":0.2676649},"labels":[],"label_agreement":null},{"id":"W2013519952","doi":"10.1179/1973947812y.0000000063","title":"<i>In vitro</i>activity (MICs and rate of kill) of AFN-1252, a novel FabI inhibitor, in the presence of serum and in combination with other antibiotics","year":2013,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Microbiology; Antibiotics; Staphylococcus aureus; Minimum inhibitory concentration; In vitro; Methicillin-resistant Staphylococcus aureus; Biology; Daptomycin; Pharmacology; Chemistry; Bacteria; Biochemistry; Vancomycin","score_opus":0.008365583363074948,"score_gpt":0.24989124071399746,"score_spread":0.24152565735092252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013519952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973612,0.0001667992,0.00028786264,0.0017639722,0.000021002883,0.00033002452,0.000006447962,7.838418e-7,0.00006193401],"genre_scores_gemma":[0.99771225,0.00035179072,0.0016578883,0.0002306115,0.000015496656,3.286282e-7,1.207943e-7,0.000012517762,0.000018998237],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99911356,0.00006192344,0.00042922774,0.0000865624,0.00019628226,0.00011245657],"domain_scores_gemma":[0.99893814,0.00019272584,0.0005471769,0.00011994544,0.0001750678,0.000026950715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055674836,0.00010023121,0.00043213085,0.0001760111,0.000006630224,0.0000073206525,0.00007945057,0.0000707937,0.000005529277],"category_scores_gemma":[0.00006645592,0.00006506847,0.000033585457,0.0002688959,0.00021331814,0.00017995342,0.000009865689,0.00021684179,4.1446356e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016047664,0.0006478317,0.093391776,0.00018297764,0.000022978778,0.0000043735295,0.0011828098,0.000012614954,0.90146863,0.000031597083,0.00003494109,0.0014147122],"study_design_scores_gemma":[0.006005933,0.0004552314,0.35267746,0.0006054815,0.000011437107,0.000026462965,0.000279936,0.0002566798,0.63935244,0.00022257016,0.000048792943,0.000057560403],"about_ca_topic_score_codex":0.00013278368,"about_ca_topic_score_gemma":0.00007331037,"teacher_disagreement_score":0.26211616,"about_ca_system_score_codex":0.000028788545,"about_ca_system_score_gemma":0.00008299487,"threshold_uncertainty_score":0.26534152},"labels":[],"label_agreement":null},{"id":"W2014158951","doi":"10.1179/joc.2005.17.6.593","title":"Antimicrobial Spectrum and Potency of Dalbavancin Tested Against Clinical Isolates from Europe and North America (2003): Initial Results from an International Surveillance Protocol","year":2005,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dalbavancin; Teicoplanin; Dalfopristin; Quinupristin; Microbiology; Enterococcus faecium; Linezolid; Broth microdilution; Vancomycin; Enterococcus; Glycopeptide; Staphylococcus aureus; Penicillin; Streptococcus pneumoniae; Medicine; Minimum inhibitory concentration; Antimicrobial; Biology; Antibiotics; Bacteria","score_opus":0.018932889955184665,"score_gpt":0.33111863844811984,"score_spread":0.3121857484929352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014158951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933156,0.00007841525,0.00024603165,0.0030331267,0.00019377848,0.002432231,0.0003164893,0.000015915843,0.00036843432],"genre_scores_gemma":[0.97432655,0.0018691412,0.018721107,0.0026840009,0.002167083,0.000028203132,0.00007226085,0.00005516855,0.000076476645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976748,0.0001301394,0.0013816644,0.0003229707,0.00028035507,0.00021004937],"domain_scores_gemma":[0.99744844,0.00023080815,0.0012213954,0.00026639752,0.0006276076,0.00020536435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034597027,0.00022562085,0.00071687595,0.00010409662,0.00003994881,0.000046040666,0.00022293505,0.00011847494,0.00006025052],"category_scores_gemma":[0.0005996394,0.00018497198,0.000092214,0.00024620688,0.00031663594,0.00028892083,0.000037437276,0.00044094864,0.0000025350203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032312255,0.0017213493,0.53155625,0.00003964225,0.000601465,0.0002096302,0.0010437797,0.000037807797,0.17434873,0.0000023496166,0.006670007,0.2514567],"study_design_scores_gemma":[0.021006923,0.0015674207,0.85458237,0.00039974926,0.000046989077,0.00007810025,0.000042516676,0.00066499773,0.017064884,0.000023699873,0.10420441,0.0003179338],"about_ca_topic_score_codex":0.00007223495,"about_ca_topic_score_gemma":0.00015821589,"teacher_disagreement_score":0.32302612,"about_ca_system_score_codex":0.00004174943,"about_ca_system_score_gemma":0.00026137507,"threshold_uncertainty_score":0.75429386},"labels":[],"label_agreement":null},{"id":"W2015258308","doi":"10.1179/joc.2008.20.1.126","title":"<i>Capnocytophaga</i>spp. DF-1 Pneumonia in an Immune-Competent 56-Year Old Man Post-CABG","year":2008,"lang":"en","type":"review","venue":"Journal of Chemotherapy","topic":"Rabies epidemiology and control","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital","funders":"","keywords":"Capnocytophaga; Pneumonia; Medicine; Bypass grafting; Flavobacteriaceae; Antibiotics; Artery; Microbiology; Internal medicine; Biology; Bacteria","score_opus":0.021763404368015844,"score_gpt":0.2984383201941854,"score_spread":0.2766749158261696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015258308","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0065915403,0.9904459,0.00000893679,0.00053759455,0.0015087591,0.0005135818,0.00003097089,0.000031642205,0.00033104033],"genre_scores_gemma":[0.0010355063,0.99489385,0.00014003091,0.001564192,0.00044415702,0.00002311164,0.00007518318,0.00010396524,0.0017199923],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99467254,0.0014725277,0.0025179242,0.00048347143,0.00010369894,0.00074984],"domain_scores_gemma":[0.9961478,0.0005410102,0.0022728236,0.00072455424,0.0002236787,0.00009013465],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0010239191,0.0007764254,0.004388807,0.0005881838,0.00015342025,0.000023156952,0.0012550321,0.0015364324,0.0007942832],"category_scores_gemma":[0.00011672141,0.00057639077,0.0020160102,0.00025880217,0.00034042238,0.00023733183,0.000056588517,0.0025526648,0.00042925967],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012869725,0.0010456233,0.00050978136,0.0011187411,0.0033346363,0.0005348711,0.0005367004,0.0000049685373,0.009937327,0.00026910825,0.0056633586,0.9757579],"study_design_scores_gemma":[0.004042475,0.0010569666,0.00076289254,0.0023544196,0.0002974938,0.005030376,0.000054228505,4.194288e-7,0.00016813194,0.00012921984,0.98554945,0.0005539226],"about_ca_topic_score_codex":0.000024215593,"about_ca_topic_score_gemma":0.000013151239,"teacher_disagreement_score":0.9798861,"about_ca_system_score_codex":0.00021520189,"about_ca_system_score_gemma":0.0004750937,"threshold_uncertainty_score":0.9997598},"labels":[],"label_agreement":null},{"id":"W2025742951","doi":"10.1179/joc.2007.19.4.392","title":"Antipneumococcal Activity of Ertapenem Compared with Gatifloxacin in a Temperature-Sensitive Murine Model of Acute Pneumonia","year":2007,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Gatifloxacin; Ertapenem; Streptococcus pneumoniae; Microbiology; Pneumonia; Medicine; Pneumolysin; Antibiotics; Internal medicine; Biology; Levofloxacin; Antibiotic resistance; Meropenem","score_opus":0.012728562962916192,"score_gpt":0.2852792858877311,"score_spread":0.2725507229248149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025742951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974755,0.000023299877,0.00081619364,0.0009861033,0.000053352676,0.00021355669,0.00000894193,0.000007343327,0.0004157129],"genre_scores_gemma":[0.99863845,0.000095667565,0.00077593094,0.00033120177,0.000075162796,8.953166e-7,9.355637e-7,0.00002396245,0.000057791567],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864966,0.000040394847,0.00060742156,0.00012718183,0.00036617884,0.00020915487],"domain_scores_gemma":[0.99860233,0.00008264201,0.0005921247,0.00018522733,0.0004038175,0.00013388022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041536693,0.00017859838,0.0007819135,0.00037512873,0.000026585267,0.000005270517,0.00008197425,0.00012123853,0.000011423362],"category_scores_gemma":[0.000016609561,0.00012283966,0.00018702477,0.00038906763,0.00013716539,0.00010430904,0.000009145928,0.00044933803,4.416252e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031904506,0.0006960975,0.02459537,0.000057406047,0.00045310243,0.00014147312,0.00062338845,0.0006517078,0.96869016,0.000013089292,0.00002513543,0.00086259504],"study_design_scores_gemma":[0.0049217436,0.0011408108,0.21665347,0.0003368197,0.0001138944,0.00054517604,0.00007845079,0.0011450436,0.7748822,0.000034451645,0.000040659685,0.00010731039],"about_ca_topic_score_codex":0.000009563564,"about_ca_topic_score_gemma":0.000032891217,"teacher_disagreement_score":0.19380802,"about_ca_system_score_codex":0.00007995066,"about_ca_system_score_gemma":0.00026252054,"threshold_uncertainty_score":0.5009256},"labels":[],"label_agreement":null},{"id":"W2031621781","doi":"10.1179/joc.2011.23.6.326","title":"Thalidomide: An Old Drug with New Action","year":2011,"lang":"en","type":"review","venue":"Journal of Chemotherapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Thalidomide; Immune system; Medicine; Drug; Tuberculosis; Cancer; Mode of action; Immunology; Drug action; Pathogenesis; Pharmacology; Biology; Pathology; Multiple myeloma; Internal medicine","score_opus":0.1237648748996664,"score_gpt":0.4159307699631318,"score_spread":0.29216589506346535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031621781","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00069739495,0.9976795,0.000058994978,0.00015081289,0.00012798648,0.0005348773,0.0000035631135,0.000015147103,0.0007317318],"genre_scores_gemma":[0.00004759915,0.9901472,0.0020092656,0.0001248366,0.0011488746,0.000005497891,0.000016627611,0.00008856384,0.006411591],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984419,0.00008638287,0.0005490006,0.00018648413,0.0004756125,0.00026063705],"domain_scores_gemma":[0.99802965,0.000059113976,0.0008022588,0.00035360432,0.00017564606,0.0005797528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027493067,0.00033561513,0.00162576,0.00031188063,0.00003424297,0.000034776578,0.00019704086,0.00016669935,0.0007124475],"category_scores_gemma":[0.00002198879,0.00017852378,0.0005052284,0.00018585086,0.00003870325,0.00019599723,0.000007938606,0.00063532306,0.000036588866],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009849466,0.0003288138,0.00014339044,0.0017429247,0.0012790725,0.00022068959,0.00011692075,2.8255181e-8,0.0000051760567,0.000005965439,0.0030348494,0.9921372],"study_design_scores_gemma":[0.005151099,0.0013607352,0.0001942717,0.008036328,0.0008087526,0.0031324252,0.000015302505,5.2335866e-7,0.00013809076,0.00005038806,0.98095334,0.00015875844],"about_ca_topic_score_codex":0.00006486116,"about_ca_topic_score_gemma":0.000014172204,"teacher_disagreement_score":0.99197847,"about_ca_system_score_codex":0.00021717325,"about_ca_system_score_gemma":0.0010864121,"threshold_uncertainty_score":0.7800801},"labels":[],"label_agreement":null},{"id":"W2032103745","doi":"10.1179/joc.2004.16.5.419","title":"Future Trends in Antimicrobial Chemotherapy: Expert Opinion on the 43<sup>rd</sup>ICAAC","year":2004,"lang":"en","type":"review","venue":"Journal of Chemotherapy","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto","funders":"Centers for Disease Control and Prevention; National Institutes of Health","keywords":"Antimicrobial; Antimicrobial chemotherapy; Expert opinion; Antibiotics; Streptococcus pneumoniae; Daptomycin; Antibiotic resistance; Medicine; Cephalosporin; Intensive care medicine; Microbiology; Biology; Bacteria; Vancomycin; Staphylococcus aureus","score_opus":0.018444235841749007,"score_gpt":0.31493077058964375,"score_spread":0.29648653474789477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032103745","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002594013,0.9928259,0.00006726381,0.0029753097,0.00080235704,0.0003380728,0.000025040506,0.000008309874,0.0003637042],"genre_scores_gemma":[0.000479875,0.99207634,0.0005428317,0.001584383,0.0047188615,0.0000054449383,0.00007364067,0.00015086909,0.00036772818],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997358,0.00024345456,0.0011399965,0.00046731517,0.00035635103,0.00043486472],"domain_scores_gemma":[0.99784535,0.000045223107,0.0011672485,0.00073111104,0.00010526814,0.00010579183],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005463269,0.00067500083,0.0014587889,0.00029074136,0.00007394506,0.00009048289,0.00101246,0.00086073374,0.00022805556],"category_scores_gemma":[0.000028685818,0.00041959764,0.0011210116,0.00037006874,0.00015337864,0.000011452142,0.00004336805,0.00077670487,0.000009830239],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052231795,0.00039567373,0.000022118113,0.0006849627,0.0005553296,0.000026507456,0.0002608199,0.000014356386,0.001858203,0.00004435055,0.04953669,0.94607866],"study_design_scores_gemma":[0.0013983195,0.0003825061,0.000055162956,0.005226362,0.00002537345,0.00023573314,0.0000415815,7.805733e-7,0.0016411414,0.0000246673,0.99053836,0.00043003415],"about_ca_topic_score_codex":0.0000032309024,"about_ca_topic_score_gemma":0.0000021479066,"teacher_disagreement_score":0.9456486,"about_ca_system_score_codex":0.00020620506,"about_ca_system_score_gemma":0.00044184548,"threshold_uncertainty_score":0.9998256},"labels":[],"label_agreement":null},{"id":"W2039702214","doi":"10.1179/joc.2006.18.6.582","title":"Gemifloxacin for the Management of Community-Acquired Respiratory Tract Infections","year":2006,"lang":"en","type":"review","venue":"Journal of Chemotherapy","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital","funders":"","keywords":"Gemifloxacin; Streptococcus pneumoniae; Respiratory tract infections; Medicine; Antibiotics; Antimicrobial; Intensive care medicine; Antibacterial agent; Respiratory tract; Antibiotic resistance; Microbiology; Respiratory system; Biology; Internal medicine","score_opus":0.08463538580862333,"score_gpt":0.3956732234291914,"score_spread":0.3110378376205681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039702214","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00043742222,0.9952756,0.0009670918,0.00044041604,0.0005300311,0.00119478,0.000025470837,0.000018664252,0.0011105221],"genre_scores_gemma":[0.00017471933,0.99785167,0.00013218034,0.0006849958,0.00060639426,0.00006124565,0.0000060859365,0.00006877518,0.0004139422],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980005,0.0002148776,0.0012303243,0.000083391744,0.0002851599,0.0001857478],"domain_scores_gemma":[0.9971675,0.0005124326,0.0014489155,0.0005254957,0.00026580167,0.00007984324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010543638,0.00029183223,0.0014644188,0.0003460321,0.00024778355,0.000019890575,0.00028575739,0.00024641922,0.00003630985],"category_scores_gemma":[0.00001881624,0.00016669238,0.0015338586,0.00038463395,0.00013549013,0.00006251885,0.000018335228,0.0007060116,0.0000028322331],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042336666,0.0017616393,0.000046796908,0.011539487,0.0026723766,0.0000130318485,0.000078946716,0.000009243944,0.0001362121,0.000101000034,0.007683576,0.9759154],"study_design_scores_gemma":[0.0015586108,0.0010614905,0.0003715114,0.005763066,0.0028814655,0.0003275468,0.00004773745,6.7915744e-7,0.000027470038,0.00007355069,0.98775744,0.00012943875],"about_ca_topic_score_codex":0.0000039114852,"about_ca_topic_score_gemma":0.0000018102091,"teacher_disagreement_score":0.98007387,"about_ca_system_score_codex":0.00016407625,"about_ca_system_score_gemma":0.00029263672,"threshold_uncertainty_score":0.6797518},"labels":[],"label_agreement":null},{"id":"W2062358462","doi":"10.1179/joc.2000.12.4.360","title":"A Pilot Study of Low Dose Hydroxyurea as a Novel Resistance Modulator in Metastatic Renal Cell Cancer","year":2000,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Vinblastine; Neutropenia; Medicine; Chemotherapy; Renal cell carcinoma; Internal medicine; Gastroenterology; Toxicity; Febrile neutropenia; Cancer; Pharmacology; Urology; Oncology","score_opus":0.026772745466838936,"score_gpt":0.29582095655836016,"score_spread":0.2690482110915212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062358462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99507,0.0023366406,0.000013045709,0.0004823677,0.000049332215,0.0005218326,0.0000040190166,0.0000054643247,0.0015173341],"genre_scores_gemma":[0.9949047,0.0004961461,0.0013064379,0.00033940753,0.00011094479,0.0000142362605,6.5340777e-7,0.00003874269,0.0027887174],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99806064,0.000059881382,0.00080833206,0.00018527616,0.00066399644,0.000221894],"domain_scores_gemma":[0.9988703,0.00006638223,0.00046025266,0.00028841276,0.00015450943,0.00016015286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031482917,0.00021288102,0.00072847854,0.0002225782,0.000019438769,0.000010720704,0.00014490528,0.000025704208,0.0007359953],"category_scores_gemma":[0.000014380413,0.00015507644,0.00014177726,0.00032787918,0.000040578896,0.00009724941,0.000005841606,0.0002687674,0.0000055230994],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039573107,0.033342082,0.022052111,0.0004590951,0.0012999272,0.0016643093,0.0070838183,0.0021881375,0.88084024,0.0000069515904,0.0012376794,0.01025251],"study_design_scores_gemma":[0.11782602,0.043088548,0.37894413,0.0023178281,0.0008653537,0.0005699068,0.0008047906,0.0004115027,0.45183527,0.0004649972,0.0022370527,0.00063457084],"about_ca_topic_score_codex":0.0002539551,"about_ca_topic_score_gemma":0.00020139167,"teacher_disagreement_score":0.429005,"about_ca_system_score_codex":0.00027164328,"about_ca_system_score_gemma":0.00030422147,"threshold_uncertainty_score":0.80586326},"labels":[],"label_agreement":null},{"id":"W2072065071","doi":"10.1179/joc.2006.18.6.634","title":"Short-Course Therapy of Gemifloxacin Effective Against Pneumococcal Pneumonia in Mice","year":2006,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Gemifloxacin; Pneumonia; Pneumococcal pneumonia; Medicine; Short course; Streptococcus pneumoniae; Antibacterial agent; Pneumococcal infections; Intensive care medicine; Microbiology; Antibiotics; Internal medicine; Biology; Pediatrics","score_opus":0.00816311570671026,"score_gpt":0.2794562789509019,"score_spread":0.27129316324419167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072065071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99475867,0.00086602726,0.00007946859,0.0020240166,0.00022875762,0.00039332247,0.0000030512274,0.000016128972,0.0016305844],"genre_scores_gemma":[0.9975534,0.0009257664,0.00009627217,0.0008163434,0.00047857652,0.00000867556,0.0000015405542,0.000037474903,0.000081947604],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983595,0.00009811834,0.00077876955,0.00015547422,0.0003536285,0.00025449783],"domain_scores_gemma":[0.9989541,0.00012767257,0.00035717685,0.00018488563,0.0002659171,0.000110251065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004597923,0.00021448455,0.000662159,0.00034119154,0.000037454076,0.0000120203895,0.000130088,0.0001689321,0.000028842047],"category_scores_gemma":[0.000023939148,0.00015996251,0.0003525064,0.00039871273,0.00011704723,0.00012882649,0.000007504932,0.0004918872,0.0000037690777],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038357917,0.0010390696,0.13287666,0.00002433231,0.00012244844,0.000101051875,0.00016886457,0.00013391547,0.8336544,0.0000140235725,0.00017589875,0.031305734],"study_design_scores_gemma":[0.0041002063,0.00090683665,0.7642715,0.00021167059,0.000030426912,0.00029177647,0.000052612904,0.000041372772,0.22127359,0.00017948088,0.008500777,0.00013977231],"about_ca_topic_score_codex":0.0000130335775,"about_ca_topic_score_gemma":0.000013373453,"teacher_disagreement_score":0.6313948,"about_ca_system_score_codex":0.00012642868,"about_ca_system_score_gemma":0.00017368478,"threshold_uncertainty_score":0.6523082},"labels":[],"label_agreement":null},{"id":"W2076658666","doi":"10.1179/joc.2010.22.5.304","title":"Telavancin Activity Against Gram-Positive Bacteria Isolated from Patients with Skin and Skin-Structure Infections","year":2010,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Microbiology; Vancomycin; Teicoplanin; Staphylococcus aureus; Enterococcus faecium; Enterococcus faecalis; Antimicrobial; Biology; Minimum inhibitory concentration; Antibiotics; Bacteria","score_opus":0.002813237421578932,"score_gpt":0.22552120982455384,"score_spread":0.2227079724029749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076658666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99818766,0.000027075614,0.00065957615,0.0004147877,0.00027315828,0.00023492172,0.00006344066,0.000013404796,0.00012599646],"genre_scores_gemma":[0.9958483,0.00007632718,0.003197314,0.0004957641,0.00029857343,7.4375663e-7,0.000011671636,0.00003654191,0.000034748147],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991331,0.000030252852,0.00026401537,0.00016302346,0.00022980507,0.00017979476],"domain_scores_gemma":[0.9987703,0.0000813184,0.0004254882,0.0001788821,0.00038265155,0.00016136159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006777901,0.00019715885,0.0004082421,0.00011408927,0.000079180056,0.000043301898,0.000072868854,0.00017032585,0.00014153213],"category_scores_gemma":[0.000041852756,0.00013839618,0.00009325214,0.00016380288,0.00013874668,0.0002121273,0.000010829564,0.000713362,0.0000013130054],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028875896,0.00040604832,0.116836704,0.000013632867,0.000321038,0.000022683796,0.00047127798,0.0000013420652,0.82747704,0.0000025204681,0.00047911823,0.051081017],"study_design_scores_gemma":[0.0050889556,0.0008909924,0.8253148,0.00014386553,0.00007493054,0.000049558133,0.00001760572,0.000010486352,0.16537346,0.00007780128,0.0028021806,0.00015533643],"about_ca_topic_score_codex":0.000024626448,"about_ca_topic_score_gemma":0.00013688196,"teacher_disagreement_score":0.7084781,"about_ca_system_score_codex":0.00006255938,"about_ca_system_score_gemma":0.00011583456,"threshold_uncertainty_score":0.56436324},"labels":[],"label_agreement":null},{"id":"W2081243791","doi":"10.1179/joc.2005.17.5.484","title":"Comparison of the Minimum Inhibitory, Mutant Prevention and Minimum Bactericidal Concentrations of Ciprofloxacin, Levofloxacin and Garenoxacin Against Enteric Gram-negative Urinary Tract Infection Pathogens","year":2005,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Urinary Tract Infections Management","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital","funders":"","keywords":"Ciprofloxacin; Microbiology; Levofloxacin; Enterobacter cloacae; Citrobacter freundii; Klebsiella pneumoniae; Minimum inhibitory concentration; Pseudomonas aeruginosa; Trimethoprim; Antimicrobial; Ampicillin; Gatifloxacin; Antibiotics; Chemistry; Escherichia coli; Biology; Bacteria","score_opus":0.020036855920303794,"score_gpt":0.30640325725933426,"score_spread":0.28636640133903046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081243791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99656963,0.00052816817,0.0007664166,0.0010878617,0.00021890752,0.00054830767,0.0000088774295,0.000010865257,0.00026098575],"genre_scores_gemma":[0.99782217,0.0008849952,0.00081044703,0.00013432196,0.00022399465,0.0000063425337,0.000003499169,0.000021327023,0.00009292216],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982537,0.00014642105,0.00094267156,0.0001631411,0.00033082286,0.00016324843],"domain_scores_gemma":[0.99820924,0.00009357347,0.0011540838,0.00019986552,0.00024918083,0.00009405378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035203158,0.00019819934,0.00053460815,0.00023582146,0.00008971737,0.00001840445,0.000065974345,0.000095772826,0.00004590689],"category_scores_gemma":[0.000056767196,0.00014864185,0.00020146505,0.00026976407,0.00019372466,0.00027740194,0.00002787766,0.00028842303,5.224584e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008940518,0.008375888,0.27316758,0.00025207998,0.00039838988,0.000011808398,0.0036801856,0.0000991855,0.6904594,0.00001713423,0.0003191257,0.022325205],"study_design_scores_gemma":[0.0055094175,0.0081904875,0.6224221,0.0006114266,0.000366589,0.00042385963,0.00064203714,0.00079114595,0.3586591,0.000089469635,0.0021140354,0.00018033541],"about_ca_topic_score_codex":0.000005883645,"about_ca_topic_score_gemma":0.000006242819,"teacher_disagreement_score":0.34925452,"about_ca_system_score_codex":0.00012155582,"about_ca_system_score_gemma":0.0000990277,"threshold_uncertainty_score":0.60614383},"labels":[],"label_agreement":null},{"id":"W2082551934","doi":"10.1179/joc.2000.12.4.299","title":"Assessment of the Susceptibility of<i>Streptococcus pneumoniae</i>to Cefaclor and Loracarbef in 13 Countries","year":2000,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cefaclor; Penicillin; Streptococcus pneumoniae; Microbiology; Antibacterial agent; Antibiotics; Medicine; Cephalosporin; Biology","score_opus":0.0073321996998420265,"score_gpt":0.29890369986538057,"score_spread":0.29157150016553857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082551934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936705,0.00011246316,0.000012061845,0.00505851,0.000082052975,0.00026485306,0.0000058327714,0.0000033800925,0.0007902986],"genre_scores_gemma":[0.998141,0.00040142995,0.000059820104,0.0011995425,0.0000705109,0.0000025986647,1.1870771e-7,0.000009614523,0.00011538175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989097,0.00005938281,0.0005379355,0.00009089945,0.00028728903,0.0001147788],"domain_scores_gemma":[0.99923325,0.00006705957,0.0002550117,0.00020783333,0.0001602685,0.00007656551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003886478,0.00009870629,0.00038978795,0.00009891179,0.000029069035,0.00000712208,0.00009199929,0.000065126536,0.00019469069],"category_scores_gemma":[0.000022104332,0.000059586677,0.00013638598,0.00022470935,0.00013515516,0.000063380634,0.00000912359,0.00023306551,7.88681e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008665428,0.00024121141,0.78182924,0.00005688649,0.000058040197,0.000004997519,0.00040222864,0.0000672861,0.2100699,0.000011518696,0.00009766695,0.0070743873],"study_design_scores_gemma":[0.0014981604,0.00061459094,0.96073556,0.00018814,0.000037490114,0.000057114612,0.000073876596,0.000018921304,0.02402498,0.00009112179,0.012607575,0.00005249266],"about_ca_topic_score_codex":0.000012704928,"about_ca_topic_score_gemma":0.000037118807,"teacher_disagreement_score":0.18604492,"about_ca_system_score_codex":0.00006287613,"about_ca_system_score_gemma":0.00020046758,"threshold_uncertainty_score":0.24298742},"labels":[],"label_agreement":null},{"id":"W2096525901","doi":"10.1179/1973947812y.0000000039","title":"ZAAPS Program results for 2010: an activity and spectrum analysis of linezolid using clinical isolates from 75 medical centres in 24 countries","year":2012,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Linezolid; Enterococcus faecium; Microbiology; Broth microdilution; Enterococcus faecalis; Clindamycin; Staphylococcus aureus; Streptococcus pneumoniae; Enterococcus; cons; Medicine; Biology; Antibiotics; Minimum inhibitory concentration; Vancomycin; Bacteria","score_opus":0.04291486435139032,"score_gpt":0.3980938916812837,"score_spread":0.35517902732989337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096525901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99488354,0.0011034791,0.0010461203,0.0023565285,0.0002581473,0.00027384819,0.000056634442,0.000008592175,0.00001313656],"genre_scores_gemma":[0.9865759,0.0017916957,0.010478783,0.00034304577,0.00076270156,0.0000010613586,0.000008042394,0.00002032792,0.000018433091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980588,0.00009589184,0.0010036597,0.00016896571,0.00037311082,0.000299594],"domain_scores_gemma":[0.9979126,0.0006083962,0.0008212893,0.00019967672,0.00018180294,0.00027625298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013769921,0.00015639662,0.0009927982,0.0002792002,0.000029833334,0.000021616695,0.0001225881,0.00023409854,0.00006224786],"category_scores_gemma":[0.00044123706,0.00011825465,0.00030332353,0.0003228179,0.00025050458,0.00023382572,0.000015386142,0.00035852045,2.0059547e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022449069,0.0027089114,0.91252875,0.00007565849,0.0023202254,0.000021892749,0.0011157178,0.000012808585,0.027098898,0.000016492852,0.0007696988,0.03088188],"study_design_scores_gemma":[0.010373061,0.0014081678,0.937092,0.00045099412,0.0014098138,0.000029521436,0.00017368137,0.0064788475,0.036339164,0.00013803496,0.005894047,0.00021266079],"about_ca_topic_score_codex":0.00015471155,"about_ca_topic_score_gemma":0.00023331244,"teacher_disagreement_score":0.03066922,"about_ca_system_score_codex":0.000084943924,"about_ca_system_score_gemma":0.0002055854,"threshold_uncertainty_score":0.48222846},"labels":[],"label_agreement":null},{"id":"W2104290226","doi":"10.1179/1973947812y.0000000062","title":"Detection, treatment, and prevention of carbapenemase-producing<i>Enterobacteriaceae</i>: Recommendations from an International Working Group","year":2013,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Etest; Colistin; Broth microdilution; Carbapenem; Carbapenem-resistant enterobacteriaceae; Agar dilution; Minimum inhibitory concentration; Medicine; Enterobacteriaceae; Regimen; Antimicrobial; Microbiology; Antibiotics; Aminoglycoside; Internal medicine; Pharmacology; Biology","score_opus":0.012974411680582942,"score_gpt":0.27702930224890004,"score_spread":0.2640548905683171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104290226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99580705,0.0001555039,0.0032078945,0.00028620462,0.00037529363,0.00009719278,0.000005052916,0.0000026467085,0.00006314871],"genre_scores_gemma":[0.99136716,0.0014619105,0.006477018,0.0000757826,0.00045286087,0.0000020543007,0.00003835359,0.00001450628,0.00011032409],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99935323,0.000051901807,0.0003156398,0.00014055076,0.000065667795,0.0000730037],"domain_scores_gemma":[0.9992605,0.000009965807,0.00040934072,0.0001606194,0.0001156437,0.00004393575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010643775,0.00009211137,0.00014301982,0.000047148875,0.000027740363,0.000041276875,0.000111664136,0.00006162246,0.00012434338],"category_scores_gemma":[0.000017477107,0.00007861455,0.00006921164,0.000033649118,0.00003367036,0.000032773394,0.000012453648,0.00003946909,6.3317947e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001504982,0.000107766835,0.089097135,0.000002532724,0.00016191689,2.4181347e-7,0.00010990968,0.0000014280931,0.8462826,0.0000025792763,0.000101302714,0.0639821],"study_design_scores_gemma":[0.0020915773,0.0012293367,0.48308945,0.0001075839,0.000041100935,0.000040206938,0.00016714094,0.000020855707,0.4962688,0.0005494611,0.016244372,0.00015011622],"about_ca_topic_score_codex":0.000036915662,"about_ca_topic_score_gemma":0.000053926076,"teacher_disagreement_score":0.3939923,"about_ca_system_score_codex":0.000024082025,"about_ca_system_score_gemma":0.000019238958,"threshold_uncertainty_score":0.3205808},"labels":[],"label_agreement":null},{"id":"W2409698911","doi":"10.1080/1120009x.2002.11782349","title":"Prevalence and Characterization of Macrolide Resistance in Clinical Isolates of <i>Streptococcus pneumoniae</i> and <i>Streptococcus pyogenes</i> from North America","year":2002,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Manitoba Health","funders":"","keywords":"Streptococcus pyogenes; Telithromycin; Ketolide; Streptococcus pneumoniae; Erythromycin; Microbiology; Efflux; Biology; Drug resistance; Macrolide Antibiotics; Antibacterial agent; Antibiotics; Bacteria; Genetics; Staphylococcus aureus","score_opus":0.013928914784051253,"score_gpt":0.2695377202944711,"score_spread":0.25560880551041987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409698911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971012,0.0012620349,0.000045361747,0.0011597208,0.00006941251,0.0002343651,0.000036091365,0.0000062307404,0.00008560484],"genre_scores_gemma":[0.98459697,0.014410615,0.00012297448,0.0006420437,0.00012427129,0.000004200325,0.000001849117,0.000016724303,0.00008034812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984445,0.000077873025,0.0010069433,0.00016700728,0.00017381445,0.0001298606],"domain_scores_gemma":[0.99848396,0.00013733264,0.0009203365,0.00018043468,0.00016125893,0.00011667955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016224047,0.00013848879,0.0005769284,0.00012361628,0.000024707313,0.000008669938,0.0000769298,0.00009833064,0.000056915742],"category_scores_gemma":[0.000054802254,0.000111656045,0.00011672717,0.00020803112,0.00021903995,0.00012661445,0.00001366511,0.00023936239,6.628058e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011573588,0.0002195422,0.6112315,0.000088444714,0.000054764474,0.000010760972,0.0003158444,8.566127e-7,0.38011768,5.700608e-7,0.000034239612,0.0078100334],"study_design_scores_gemma":[0.0023929405,0.00060963095,0.9633653,0.00041087143,0.00007279114,0.000027341059,0.00002061873,0.000053743595,0.027065426,0.00003497151,0.005847451,0.000098887176],"about_ca_topic_score_codex":0.0000040031496,"about_ca_topic_score_gemma":0.000012999143,"teacher_disagreement_score":0.35305226,"about_ca_system_score_codex":0.000017205228,"about_ca_system_score_gemma":0.00004299695,"threshold_uncertainty_score":0.45532015},"labels":[],"label_agreement":null},{"id":"W2411994009","doi":"10.1080/1120009x.2004.11782402","title":"Resistance Trends in <i>Haemophilus influenzae</i> (PROTEKT Years 1–3 [1999–2002])","year":2004,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Haemophilus influenzae; Microbiology; Pasteurellaceae; Resistance (ecology); Medicine; Biology; Antibiotics; Ecology","score_opus":0.013490655221886503,"score_gpt":0.2883297120216597,"score_spread":0.27483905679977316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411994009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98130345,0.0010014033,0.00008801095,0.012808091,0.00023022623,0.000100518155,0.0000019087422,0.000020722247,0.0044456613],"genre_scores_gemma":[0.98915404,0.00045107206,0.00075400464,0.007833081,0.000554217,0.0000036048714,5.282981e-7,0.000034131244,0.0012153282],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99890405,0.000023153538,0.00047076066,0.00010869634,0.00029476598,0.00019859221],"domain_scores_gemma":[0.9993246,0.000017411603,0.00024379774,0.000181697,0.000094503914,0.00013798042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022313076,0.00012333046,0.00034700424,0.00043144976,0.00003199675,0.000015228998,0.00009942171,0.000110832676,0.00015308993],"category_scores_gemma":[0.000028684066,0.00010069826,0.00019544062,0.0005440692,0.00006147776,0.0001289323,0.00000557824,0.00040824804,0.000015917089],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036363455,0.0034302627,0.05912567,0.00018640303,0.000692013,0.0042936774,0.005066221,0.0013487014,0.74161065,0.00075094035,0.03091965,0.14893945],"study_design_scores_gemma":[0.016373519,0.00094559346,0.3314274,0.00058365514,0.00005502187,0.0012673873,0.000070159724,0.000002246701,0.020288328,0.0020090404,0.6267117,0.0002659128],"about_ca_topic_score_codex":0.0000066882467,"about_ca_topic_score_gemma":0.000030279223,"teacher_disagreement_score":0.72132236,"about_ca_system_score_codex":0.00020437609,"about_ca_system_score_gemma":0.00017642719,"threshold_uncertainty_score":0.41063556},"labels":[],"label_agreement":null},{"id":"W2419028065","doi":"10.1080/1120009x.2001.11782329","title":"Infectious Diseases: Career Preparation","year":2001,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Infectious disease (medical specialty); Medicine; Global health; Political science; Economic growth; Disease; Public health; Nursing; Pathology","score_opus":0.03428793942170228,"score_gpt":0.42249251665926185,"score_spread":0.3882045772375596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2419028065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9239039,0.002233128,0.0017682893,0.019989487,0.0022462925,0.00044349118,0.0000056257945,0.00007382288,0.049336],"genre_scores_gemma":[0.939113,0.0031736016,0.00023630663,0.050672617,0.0024214801,0.000012918329,0.0000039566817,0.000032010306,0.004334095],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99864715,0.00015787175,0.0006009006,0.000077799465,0.00026290858,0.00025338843],"domain_scores_gemma":[0.99861985,0.00019515974,0.0005255294,0.00015764157,0.0003430966,0.00015872215],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037185324,0.00009522209,0.0002907107,0.000118534226,0.00021961707,0.000008003364,0.00012546242,0.00011056991,0.001337932],"category_scores_gemma":[0.00006936352,0.000071832204,0.00012930654,0.0001485948,0.000018040178,0.0002408416,0.000012226525,0.00037114433,0.00007027294],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007728049,0.00014141008,0.6184742,0.000104103085,0.000096570635,0.00003626035,0.0032575324,0.000011614285,0.00048582256,0.00028482982,0.34346238,0.03287252],"study_design_scores_gemma":[0.0029133032,0.00035913664,0.11912142,0.000057238438,0.000030951003,0.00005033215,0.00022499933,0.00001001652,0.000047316167,0.0032430997,0.8738325,0.0001096405],"about_ca_topic_score_codex":0.000020721633,"about_ca_topic_score_gemma":0.00004088949,"teacher_disagreement_score":0.5303702,"about_ca_system_score_codex":0.00041655477,"about_ca_system_score_gemma":0.0009263518,"threshold_uncertainty_score":0.99957496},"labels":[],"label_agreement":null},{"id":"W2428638391","doi":"10.1080/1120009x.2001.11782324","title":"Community Acquired Pneumonia (CAP): An Update","year":2001,"lang":"en","type":"review","venue":"Journal of Chemotherapy","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; University of Manitoba; Mount Sinai Hospital","funders":"","keywords":"Community-acquired pneumonia; Pneumonia; Pneumonia severity index; Intensive care medicine; Empiric treatment; Etiology; Medicine; Internal medicine; Antibiotics; Biology","score_opus":0.07410428960654857,"score_gpt":0.3937359718405865,"score_spread":0.31963168223403793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2428638391","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015574035,0.9954239,0.00005009168,0.0009870224,0.0005493892,0.00036146026,0.000011308836,0.000044530218,0.0010148702],"genre_scores_gemma":[0.00007209422,0.9957036,0.0001234139,0.0021981178,0.0012283829,0.000006271437,0.000019237994,0.00010559358,0.0005432877],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974738,0.0005375942,0.0011752946,0.00014220245,0.00038282745,0.0002883085],"domain_scores_gemma":[0.9972445,0.00008952494,0.001299762,0.0006970277,0.00027998074,0.00038922383],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00079341186,0.00043321992,0.002409802,0.0004650585,0.00019964656,0.000051708583,0.00042950417,0.0004570479,0.00036558832],"category_scores_gemma":[0.00004619043,0.00028896288,0.0011663234,0.00048064743,0.000114515904,0.00019172845,0.000024433908,0.0014501633,0.000052141226],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042858683,0.0007685403,0.000044284017,0.0021922952,0.00069892046,0.00018590677,0.00011080363,3.9185568e-7,0.00035076556,0.000009756071,0.0021281594,0.99346733],"study_design_scores_gemma":[0.0010823216,0.000988883,0.00011728033,0.005964533,0.0009976429,0.0079413485,0.000025148358,0.0000010506586,0.000018068235,0.00007568352,0.9825485,0.00023956133],"about_ca_topic_score_codex":0.0000052985743,"about_ca_topic_score_gemma":0.000004652493,"teacher_disagreement_score":0.9932278,"about_ca_system_score_codex":0.0002187208,"about_ca_system_score_gemma":0.0006516091,"threshold_uncertainty_score":0.99995625},"labels":[],"label_agreement":null},{"id":"W2474139679","doi":"10.1080/1120009x.2001.11782321","title":"Infectious Diseases on the 21<sup>st</sup> Century Doorstep","year":2001,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Modalities; Infectious disease (medical specialty); Health professionals; Medicine; Clinical microbiology; Disease; Health care; Political science; Sociology; Biology; Pathology; Microbiology; Social science","score_opus":0.015752972708512246,"score_gpt":0.30370404730233436,"score_spread":0.28795107459382213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2474139679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97500074,0.0010877496,0.000113059636,0.014655599,0.0001550839,0.00020360762,0.000003716982,0.000025632526,0.008754817],"genre_scores_gemma":[0.9872311,0.0060829264,0.000021919956,0.0041651446,0.001167989,0.000003941159,0.0000015333951,0.00002742473,0.0012980582],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988027,0.00007157268,0.0003045518,0.00010361441,0.0004774539,0.00024006514],"domain_scores_gemma":[0.99906635,0.00014609992,0.0001485354,0.00021345547,0.00022852034,0.00019705425],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027858088,0.00013536656,0.0002753859,0.0001880284,0.00013517865,0.000055135835,0.00011533402,0.00006956911,0.0015965751],"category_scores_gemma":[0.00009636963,0.0000726451,0.00029207824,0.0003257596,0.00008075007,0.00010243756,0.000012251197,0.00047438458,0.000050606897],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006398205,0.005227263,0.2630557,0.00015643914,0.0018066278,0.0011906804,0.0014915483,0.0008703856,0.012798964,0.0016080766,0.21595795,0.48943815],"study_design_scores_gemma":[0.008290634,0.0040942896,0.07150738,0.00042557868,0.00015065909,0.0036860234,0.00045913726,0.0010497058,0.0043292143,0.0014020206,0.90433013,0.0002752092],"about_ca_topic_score_codex":0.000010558687,"about_ca_topic_score_gemma":0.000001653275,"teacher_disagreement_score":0.6883722,"about_ca_system_score_codex":0.000122131,"about_ca_system_score_gemma":0.00011386578,"threshold_uncertainty_score":0.9993161},"labels":[],"label_agreement":null},{"id":"W2766177920","doi":"10.1080/1120009x.2017.1389807","title":"Effect of vancomycin initial dosing on time to systemic inflammatory response syndrome resolution in patients with methicillin-resistant <i>Staphylococcus aureus</i> bacteremia","year":2017,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Regional Hospital","funders":"","keywords":"Vancomycin; Medicine; Bacteremia; Systemic inflammatory response syndrome; Staphylococcus aureus; Dosing; Sepsis; Internal medicine; Cohort; Hazard ratio; Methicillin-resistant Staphylococcus aureus; Surgery; Gastroenterology; Anesthesia; Antibiotics; Microbiology","score_opus":0.0070124187867246215,"score_gpt":0.2736180815291428,"score_spread":0.2666056627424182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766177920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980627,0.00009562931,0.000077905686,0.0004730988,0.00015304549,0.0009217589,0.00001917557,0.00001378111,0.00018291142],"genre_scores_gemma":[0.9988507,0.000015307645,0.0005492847,0.00029411993,0.00011350421,0.0000058754767,0.0000020475443,0.00006625401,0.00010287949],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997003,0.0004810839,0.0010390054,0.00026764252,0.00084289734,0.00036634452],"domain_scores_gemma":[0.9964462,0.0005880739,0.0015450626,0.0007384209,0.00046764239,0.00021459935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026242984,0.0003382232,0.0011357972,0.0005520593,0.00012464062,0.000052275594,0.00040015383,0.00022844835,0.000045643104],"category_scores_gemma":[0.000758064,0.0002444761,0.00022996616,0.00019646967,0.00017619287,0.00022601314,0.00003409045,0.0006259534,0.000018230246],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19588497,0.0002634536,0.05252974,0.00042285112,0.00020279514,0.0003464259,0.00031322357,0.00012442775,0.74695855,0.0000023385014,0.0005492402,0.0024019456],"study_design_scores_gemma":[0.021935927,0.015867779,0.63467586,0.011629512,0.00012898624,0.00003990673,0.00001759251,0.000011579172,0.31413436,0.000011370006,0.0011693082,0.00037778713],"about_ca_topic_score_codex":0.000008510717,"about_ca_topic_score_gemma":0.000005340198,"teacher_disagreement_score":0.58214617,"about_ca_system_score_codex":0.0005740885,"about_ca_system_score_gemma":0.00033343947,"threshold_uncertainty_score":0.99694467},"labels":[],"label_agreement":null},{"id":"W3128010065","doi":"10.1080/1120009x.2021.1879581","title":"Recovery of borderline oxacillin-resistant <i>Staphylococcus pseudintermedius</i> (BORSP) from bone and soft tissue of a rheumatoid arthritis patient with severe osteoporosis: transmission from the family dog","year":2021,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital; Saskatchewan Health Authority; University of Saskatchewan","funders":"","keywords":"Staphylococcus pseudintermedius; Clindamycin; Medicine; Erythromycin; Rheumatoid arthritis; Arthritis; Osteoporosis; Staphylococcus aureus; Antibiotics; Surgery; Dermatology; Internal medicine; Staphylococcus; Microbiology; Biology; Bacteria","score_opus":0.0063899664519588145,"score_gpt":0.2287528434200178,"score_spread":0.222362876968059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128010065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9379355,0.055712465,0.0025635215,0.0028491386,0.00013609587,0.000338537,0.00035116766,0.000011074189,0.00010252082],"genre_scores_gemma":[0.9293574,0.057246953,0.011671185,0.0014380098,0.00014723022,0.0000043981513,0.000029940935,0.000065183274,0.000039701332],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970339,0.00011609212,0.0014487338,0.00032917783,0.00079365144,0.0002784517],"domain_scores_gemma":[0.9966306,0.00046663787,0.0013826579,0.00046155197,0.00085245795,0.00020607884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002690537,0.00034359543,0.001336322,0.00009889006,0.000070293114,0.000032781558,0.00017588187,0.00018159779,0.00020953569],"category_scores_gemma":[0.00010643797,0.00022311269,0.00031015833,0.00030944598,0.00031284255,0.00014876535,0.000029872504,0.0004409094,7.497574e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070790304,0.0004614348,0.0019431112,0.00009809194,0.0005303009,0.00032691285,0.0023164938,0.000019432993,0.85830355,0.000002550629,0.0044983523,0.12442071],"study_design_scores_gemma":[0.01284086,0.002947413,0.015886847,0.00919312,0.0001779875,0.00030567154,0.0033381581,0.000020293443,0.8956106,0.00050682866,0.058789253,0.00038298845],"about_ca_topic_score_codex":0.0002079085,"about_ca_topic_score_gemma":0.000105125364,"teacher_disagreement_score":0.12403773,"about_ca_system_score_codex":0.00006597926,"about_ca_system_score_gemma":0.00055254245,"threshold_uncertainty_score":0.9098271},"labels":[],"label_agreement":null},{"id":"W3212713753","doi":"10.1080/1120009x.2021.1995251","title":"Urinary tract infection in a human male patient with <i>Staphylococcus pseudintermedius</i> transmission from the family dog","year":2021,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital; Saskatchewan Health Authority; University of Saskatchewan","funders":"","keywords":"Urinary system; Transmission (telecommunications); Adult male; Animal model","score_opus":0.010989878641154053,"score_gpt":0.2687635005438797,"score_spread":0.2577736219027257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212713753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99262565,0.0020124598,0.001041618,0.0028574013,0.00012127915,0.00023925926,0.00000605891,0.000011124286,0.0010851247],"genre_scores_gemma":[0.9940324,0.0016971494,0.0011120695,0.0026804667,0.00029231622,0.0000043467803,0.000005756562,0.00003754287,0.00013797643],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99845207,0.000093955256,0.0005928031,0.00019686406,0.00043708994,0.00022722305],"domain_scores_gemma":[0.9988851,0.00011394525,0.0003796851,0.00025485584,0.00024877858,0.00011763259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019464396,0.00020059934,0.00044870732,0.00009919602,0.00007563723,0.00003480207,0.000113019596,0.00010915028,0.0002759279],"category_scores_gemma":[0.000020190557,0.000121295496,0.00024119938,0.0003131798,0.00010201304,0.0001369786,0.0000103855,0.00059394236,0.0000021925825],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022040228,0.0019952527,0.15248711,0.000052661275,0.0001672511,0.003205812,0.0018863659,0.000032320724,0.80884624,0.0000044630924,0.0066257464,0.022492755],"study_design_scores_gemma":[0.0095449025,0.003138373,0.6546821,0.0023649207,0.00012868279,0.0027535562,0.0005592834,0.000018881517,0.25180954,0.0002435729,0.074468434,0.00028774713],"about_ca_topic_score_codex":0.000069194684,"about_ca_topic_score_gemma":0.00002409104,"teacher_disagreement_score":0.5570367,"about_ca_system_score_codex":0.0001519215,"about_ca_system_score_gemma":0.00026718213,"threshold_uncertainty_score":0.49462867},"labels":[],"label_agreement":null},{"id":"W4390978892","doi":"10.1080/1120009x.2024.2302736","title":"Review of real-world experience with lurbinectedin in relapsed/refractory small cell lung cancer","year":2024,"lang":"en","type":"review","venue":"Journal of Chemotherapy","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"American Society of Hematology","keywords":"Food and drug administration; Medicine; Refractory (planetary science); Clinical trial; Lung cancer; Drug approval; Intensive care medicine; Family medicine; Drug; Oncology; Internal medicine; Medical emergency; Pharmacology","score_opus":0.04827015999822119,"score_gpt":0.42860374637497983,"score_spread":0.3803335863767586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390978892","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018463827,0.9955427,0.0000023669675,0.00073354633,0.0002795603,0.0011546029,0.000013139088,0.000014102188,0.0020753585],"genre_scores_gemma":[0.000017156166,0.9955383,0.00029495487,0.0004990149,0.00059769186,0.0001207475,0.000003289283,0.000120531855,0.0028083078],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99671763,0.00014190187,0.0016150328,0.00033693248,0.0008156947,0.0003728029],"domain_scores_gemma":[0.99725115,0.00020169621,0.0014309989,0.00043755423,0.00048906484,0.00018955124],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007746543,0.00049229426,0.003683631,0.00075427437,0.00001950762,0.000015090005,0.00039136116,0.00014860735,0.0003228431],"category_scores_gemma":[0.00009376933,0.00027702525,0.00066785706,0.0014400652,0.00014853044,0.00007021194,0.000051422518,0.0015910486,0.0000031716058],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028993087,0.0002601647,0.0005551407,0.6451918,0.0011446712,0.00047809246,0.00079336466,3.0913216e-7,0.00003201306,0.0000036908561,0.05500084,0.29625],"study_design_scores_gemma":[0.0008560154,0.00033234272,0.000035176345,0.4262411,0.00103638,0.0000885361,0.00001693644,8.162939e-7,0.00004077617,0.0000019736283,0.5712008,0.00014916553],"about_ca_topic_score_codex":0.00013577743,"about_ca_topic_score_gemma":0.0001130418,"teacher_disagreement_score":0.51619995,"about_ca_system_score_codex":0.0013060656,"about_ca_system_score_gemma":0.0027748083,"threshold_uncertainty_score":0.9999682},"labels":[],"label_agreement":null},{"id":"W4391723324","doi":"10.1080/1120009x.2024.2313908","title":"<i>In vitro</i> killing of drug susceptible and multidrug resistant bacteria by amikacin considering pulmonary drug concentrations based on an inhaled formulation","year":2024,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Royal University Hospital; Saskatchewan Health Authority","funders":"Royal University Hospital Foundation","keywords":"Amikacin; Microbiology; Antibiotics; Drug resistance; Drug; Acinetobacter baumannii; Medicine; Pseudomonas aeruginosa; Pharmacology; Staphylococcus aureus; Biology; Bacteria","score_opus":0.005954199682156071,"score_gpt":0.2508076887464087,"score_spread":0.2448534890642526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391723324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99725974,0.0009791504,0.0009156777,0.0004507377,0.00015814736,0.00012876668,0.000027909078,0.0000053273857,0.000074524076],"genre_scores_gemma":[0.9956878,0.0005597231,0.0032314623,0.00021818269,0.00012824769,0.000001044406,0.000036826405,0.000028509789,0.00010819924],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989292,0.00007842724,0.00049261446,0.00019412157,0.00015345307,0.00015215855],"domain_scores_gemma":[0.99941295,0.00005699904,0.00022639958,0.00015888673,0.000078325924,0.00006641093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036827594,0.00014573647,0.00023448517,0.0000924335,0.00003725789,0.000052783005,0.000095370764,0.00007614629,0.000021896494],"category_scores_gemma":[0.000022005186,0.00013034495,0.00007776695,0.0000895031,0.00006261983,0.00003993815,0.000009004362,0.00012521817,2.9104342e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009812283,0.000099051584,0.0010133388,0.000071442075,0.000028813793,0.000022911636,0.00021918041,0.00011489576,0.9960786,0.000017088158,0.00047540545,0.0008780502],"study_design_scores_gemma":[0.00093848497,0.00016388723,0.0010240154,0.00022590293,0.000012681681,0.000027129096,0.00016377214,0.005230126,0.9885535,0.00008679296,0.0034348848,0.0001388271],"about_ca_topic_score_codex":0.000010274897,"about_ca_topic_score_gemma":0.000012307663,"teacher_disagreement_score":0.007525098,"about_ca_system_score_codex":0.00003660204,"about_ca_system_score_gemma":0.000102505335,"threshold_uncertainty_score":0.53153133},"labels":[],"label_agreement":null},{"id":"W4399221811","doi":"10.1080/1120009x.2024.2359838","title":"Elevated CK from immune checkpoint inhibitor- related hypophysitis: a case report","year":2024,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Muscle and Compartmental Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"","keywords":"Hypophysitis; Medicine; Cancer research; Internal medicine; Pituitary gland","score_opus":0.010774405562299496,"score_gpt":0.27351564096458975,"score_spread":0.2627412354022903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399221811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866687,0.007910833,0.00006209837,0.0028150626,0.00046940998,0.00015207595,0.0000033529743,0.000060504288,0.0018579536],"genre_scores_gemma":[0.997106,0.00043762414,0.00041261758,0.00046502068,0.00041172974,0.0000026758787,0.000017492903,0.000043472624,0.0011033352],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99846345,0.000028089364,0.0008484944,0.00017094697,0.00032112023,0.00016788745],"domain_scores_gemma":[0.9992144,0.000038236503,0.00026856057,0.00022980977,0.00010824683,0.00014072412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022234951,0.0001649247,0.0004242641,0.00013474829,0.00003553408,0.000045925866,0.000064700354,0.000094346644,0.00083559216],"category_scores_gemma":[0.000022970356,0.00012800304,0.00038967413,0.000276273,0.000042160456,0.00014791702,0.000011569735,0.0003926087,0.00004057549],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008878421,0.0006265669,0.000602209,0.000100673285,0.0017009476,0.29356128,0.001728525,0.0000051237057,0.64728504,0.000037567752,0.012283238,0.041181017],"study_design_scores_gemma":[0.012601901,0.0019591053,0.021420492,0.0025192723,0.0006486018,0.44350776,0.0014347549,0.0011045749,0.45576993,0.006813746,0.051633745,0.00058612117],"about_ca_topic_score_codex":0.00007684617,"about_ca_topic_score_gemma":0.0000026725286,"teacher_disagreement_score":0.1915151,"about_ca_system_score_codex":0.00010949851,"about_ca_system_score_gemma":0.0001603895,"threshold_uncertainty_score":0.9149148},"labels":[],"label_agreement":null},{"id":"W4402582237","doi":"10.1080/1120009x.2024.2402177","title":"Reversible chemoresistance of pancreatic cancer grown as spheroids","year":2024,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Cancer Institute; National Institutes of Health; Rolfe Pancreatic Cancer Foundation; Johns Hopkins University","keywords":"Spheroid; Pancreatic cancer; Cancer; Cancer research; Oncology; Internal medicine; Medicine; Biology; Genetics; Cell culture","score_opus":0.02158684788261269,"score_gpt":0.35631920965416713,"score_spread":0.33473236177155447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402582237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95949626,0.02181598,0.00029860446,0.00613517,0.00019364561,0.00014957228,0.000003080581,0.000013503393,0.011894205],"genre_scores_gemma":[0.9636141,0.0151790045,0.0040916493,0.000747562,0.0005849137,0.000005444461,8.7434756e-7,0.000032851825,0.01574359],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987398,0.000034080276,0.0004591183,0.000114445094,0.00045883845,0.000193751],"domain_scores_gemma":[0.99908876,0.0001747515,0.00017428113,0.00016530706,0.00025682224,0.0001400661],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004886184,0.00011380854,0.0006417771,0.00014064848,0.000023191607,0.0000130716335,0.00012824505,0.00009818894,0.0026908128],"category_scores_gemma":[0.00009138702,0.00008014974,0.00021114724,0.00031128165,0.000137796,0.00009699761,0.000009433555,0.0003068775,0.000019775778],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007278322,0.0008845324,0.3204269,0.0035626292,0.004543297,0.001391527,0.0030339952,0.000007838689,0.4056373,0.0016428211,0.17679529,0.07479553],"study_design_scores_gemma":[0.019774832,0.007872852,0.17538902,0.012912501,0.002963601,0.002738305,0.0014283529,0.0013938729,0.50475407,0.017051836,0.252983,0.0007377329],"about_ca_topic_score_codex":0.000042440035,"about_ca_topic_score_gemma":0.000005235398,"teacher_disagreement_score":0.14503789,"about_ca_system_score_codex":0.00016912694,"about_ca_system_score_gemma":0.00091882737,"threshold_uncertainty_score":0.99822086},"labels":[],"label_agreement":null},{"id":"W4403431163","doi":"10.1080/1120009x.2024.2416348","title":"Case report: hypertrophic osteoarthropathy improves with immune checkpoint inhibitor therapy","year":2024,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Hypertrophic osteoarthropathy and related conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Hypertrophic osteoarthropathy; Medicine; Immune system; Dermatology; Immunology","score_opus":0.010722749265720564,"score_gpt":0.250693520089474,"score_spread":0.23997077082375343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403431163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9626431,0.026660582,0.00026634277,0.008426756,0.0009941198,0.00033769518,0.000005270192,0.000090347996,0.0005757974],"genre_scores_gemma":[0.99272406,0.002743675,0.0011206666,0.000536959,0.0015310307,0.000009691026,0.000006871811,0.000097335134,0.0012296872],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.99795765,0.000056740533,0.0009386935,0.00027384827,0.00046933867,0.00030371037],"domain_scores_gemma":[0.9985654,0.00006916437,0.0003613654,0.0003979961,0.0003638583,0.00024221995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004704857,0.0003006361,0.00061483256,0.0003294834,0.00013673064,0.000091692964,0.00008849914,0.00020961554,0.00032591508],"category_scores_gemma":[0.000039289018,0.00017765745,0.00047117352,0.00045020934,0.00022789607,0.00028482216,0.000011091734,0.000916516,0.000027650878],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013461795,0.0003274875,0.000060753224,0.000091722155,0.00064200425,0.43958414,0.0012519105,0.000007585678,0.48146296,0.000029003375,0.00034203046,0.074854225],"study_design_scores_gemma":[0.0057632914,0.005814168,0.00018649326,0.000834727,0.00022727346,0.8408845,0.0003603609,0.00008869276,0.11535975,0.00022552862,0.030007783,0.00024741306],"about_ca_topic_score_codex":0.0000061522487,"about_ca_topic_score_gemma":0.0000011047533,"teacher_disagreement_score":0.40130037,"about_ca_system_score_codex":0.00009362564,"about_ca_system_score_gemma":0.0005440295,"threshold_uncertainty_score":0.7244661},"labels":[],"label_agreement":null},{"id":"W4414306402","doi":"10.1080/1120009x.2025.2561969","title":"Characterizing pulmonary adverse events associated with the immune checkpoint inhibitor avelumab: a FAERS-based pharmacovigilance study from 2013 to 2024","year":2025,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pneumonitis; Adverse effect; Pneumonia; Pharmacovigilance; Respiratory distress; Respiratory failure; Pulmonary edema; Lung cancer; Pulmonary toxicity","score_opus":0.011283008644933243,"score_gpt":0.28717363617491565,"score_spread":0.2758906275299824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414306402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97401077,0.0012831469,0.00017555199,0.022898419,0.0006106679,0.00083056034,0.000015834019,0.00002228882,0.00015273575],"genre_scores_gemma":[0.9895045,0.0002119099,0.00015662915,0.008200853,0.00031300075,0.000025134706,0.000007003813,0.000036488123,0.0015444773],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99822545,0.00011644623,0.0006551454,0.00021674357,0.00052516523,0.0002610446],"domain_scores_gemma":[0.9986723,0.00012622988,0.0005587778,0.00029455882,0.0002453928,0.0001027502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007356409,0.00025597416,0.0005587912,0.00019630091,0.00011255283,0.000022451053,0.000271819,0.00007510775,0.0003262171],"category_scores_gemma":[0.000030717736,0.00015550262,0.00029639454,0.0005699376,0.000052957006,0.00012618296,0.000021041154,0.00045117846,0.0000063175175],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027936358,0.0019171011,0.0499252,0.000033580898,0.0027739482,0.0001680077,0.0015521089,0.00002054363,0.9002729,2.0047739e-7,0.0037010505,0.0116989855],"study_design_scores_gemma":[0.02547164,0.0021530346,0.7022122,0.0023249104,0.00045991282,0.000034098477,0.0014654981,0.0001765385,0.23955125,0.00001157512,0.025802933,0.00033641272],"about_ca_topic_score_codex":0.00008568193,"about_ca_topic_score_gemma":0.000019313324,"teacher_disagreement_score":0.66072166,"about_ca_system_score_codex":0.00035543356,"about_ca_system_score_gemma":0.00035972142,"threshold_uncertainty_score":0.6341213},"labels":[],"label_agreement":null},{"id":"W68924427","doi":"10.1080/1120009x.2004.11782371","title":"The Role of PK/PD Parameters to Avoid Selection and Increase of Resistance: Mutant Prevention Concentration","year":2004,"lang":"en","type":"review","venue":"Journal of Chemotherapy","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Royal University Hospital","funders":"Allergan","keywords":"Levofloxacin; Moxifloxacin; Gemifloxacin; Gatifloxacin; Antimicrobial; Streptococcus pneumoniae; Microbiology; Minimum inhibitory concentration; Ciprofloxacin; Population; Pseudomonas aeruginosa; Drug resistance; Ofloxacin; Bacterial growth; Biology; Bacteria; Antibiotics; Medicine","score_opus":0.008633022891772063,"score_gpt":0.29006403431515493,"score_spread":0.2814310114233829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W68924427","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10555486,0.89338803,0.00052836235,0.00002871399,0.000091010326,0.00035044525,0.000010522555,0.000001294753,0.000046765897],"genre_scores_gemma":[0.035298742,0.96285856,0.0015888255,0.0000132058485,0.00011392669,0.0000025041484,0.000009751725,0.000024017285,0.00009047034],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99859226,0.0001487142,0.00079624535,0.0001490743,0.00019018185,0.00012352563],"domain_scores_gemma":[0.99803054,0.000042684384,0.0014753442,0.0001791126,0.00021312984,0.000059188587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046990835,0.00017522789,0.0005906043,0.000045013403,0.000040965362,0.000022086007,0.00017871492,0.00019316001,0.000003921022],"category_scores_gemma":[0.00010896741,0.00012047237,0.0002587045,0.000119472024,0.00008381214,0.000007035868,0.000014419401,0.0001267798,2.047815e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021189821,0.00024238728,0.00034215796,0.0060168365,0.0011516118,0.0000028464399,0.00019418164,0.000016822307,0.228168,0.00016025086,0.0003133806,0.76127255],"study_design_scores_gemma":[0.0013349567,0.0013583042,0.00034956328,0.014228974,0.00047299455,0.00013680432,0.0001385037,0.000001681165,0.2256558,0.0011552682,0.7548095,0.00035768162],"about_ca_topic_score_codex":0.000004271799,"about_ca_topic_score_gemma":0.000015171909,"teacher_disagreement_score":0.76091486,"about_ca_system_score_codex":0.0000590332,"about_ca_system_score_gemma":0.00039049383,"threshold_uncertainty_score":0.49127206},"labels":[],"label_agreement":null}]}